WELCOME TO EECP

VSK

Enhanced External Counter Pulsation (EECP) Therapy

Topics to be covered.Company profile.What is EECP ?Working principle of EECP.Why EECP?Objective of the EECP.Who is EECP for?Mode of therapy.Accreditations.Limitations of EECP?Global and Indian market of EECP.Competitors.

Company profile.VSK Medical Limited-a global market leader in

ECP&EECP

Address:-1st Floor No.342, 1st Floor East Facing9th Main Dollars Colony, J.P Nagar, 4th Phase,Bangalore, 560078, India

Main products: EECP ALL IN ONE MODEL, EECP PAEDIATRIC MODEL AND EECP MOVABLE MODEL.(By PSK China & Vasomedical Solution.)

Main market: Eastern Asia, South Asia, Middle East, Central America and Southeast Asia. Apart from USA & China.

Vasomedical Lumenair™ All-In-One EECP® Therapy System

Vasomedical AngioNew®-V Mobile EECP® Therapy System

Vasomedical AngioNew®-VI All-In-One EECP® Therapy System

EECP ?EECP stands for Enhanced External

Counterpulsation Therapy.

It’s a new method to relieve heart pain by creating new vessels(collaterals) in the heart by pushing blood into the heart.

EECP helps grow new collaterals for blood to flow, like a natural bypass around blocked arteries.

EECP is a non-invasive treatment.

Working principle of EECP.Series of 3 cuffs wrapped around calves,

lower thighs, upper thighs and buttocks.Cuffs sequentially inflate with air when

the heart relaxes and deflate when the heart pumps.

Why EECP?

Objective of EECP.To assess the effectiveness, and cost

effectiveness of EECP in patients with severe anginal symptoms, secondary to chronic coronary disease, who are not candidates for surgical/percutaneous revascularization procedures (e.g., angioplasty, coronary bypass surgery).

Benefits of

EECP

Neurological

disorder

Erectile dysfunctio

n

Stroke and kidney

impairment

Diabetic patient.

Sports Enhan-cemen

t

Vision and

hearing

disorder

Autoim-

mune diseas

e

Lymph-atic syste

m

Who is EECP for?

EECP therapy is indicated for patients with coronary artery disease who either cannot undergo angioplasty or bypass surgery, or have persistent anginal symptoms following angioplasty or bypass surgery.

Patients with heart pain, low energy level, shortness of breath, fatigue and diabetic patients.

CAD – Coronary Artery DiseaseCHD – Coronary Heart DiseasePVD – Peripheral Vascular DiseaseED – Erectile DysfunctionCardiac chest painCongestive heart failureHigh blood pressureCardio-myopathyPeripheral neuropathyPeripheral vascular diseaseEdema, or venous insufficiencyChronic fatigue Intestinal vascular insufficiencyLymphatic System         Parkinson’s diseasekidney diseasePeripheral vascular disease hearing loss and tinnitus vision impairment

    

Mode of therapy.A total of 35 hours is required.

Regimen:1 hour daily.

At least 5 days per week for 7 weeks.

Accreditations.FDA approved.CE certified.Method adopted by various medical

branches like :American Medicare.European Society of Cardiology (ESC).Chinese Medical Association (CMA).American College of Cardiology (ACC)

etc..

Limitations of EECP?Aortic stenosis , Dialated Cardiomyopathy .Uncontrolled hypertension.Blood Pressure >160/100mmhg.Brain Hemorrhage.Heart Rate >120bpm.Pregnant women.Deep vein Thrombosis.Infection on limbs.Arrhythmias that interfere with machine

triggering.

Global and Indian market of EECP.Major market in

CHINA and USA.Progressive stage

in INDIA with numerous centers.

Bangalore ChennaiDelhi Deharadun Mumbai

JaipurKolkataKeralaPuneSuratBihar etc..

Competitors Scottcare.EUROPA(IECP).Renew.OMAY China.Yathi Mediequip.

Thank you